Literature DB >> 26699602

Predictable and SuStainable Implementation of National Cardiovascular Registries (PASSION) infrastructure: A think tank report from Medical Device Epidemiological Network Initiative (MDEpiNet).

Emily P Zeitler1, Sana M Al-Khatib1, Joseph P Drozda2, Larry G Kessler3, Ajay J Kirtane4, David F Kong1, John Laschinger5, Danica Marinac-Dabic5, Marie-Claude Morice6, Terrie Reed5, Art Sedrakyan7, Kenneth M Stein8, James Tcheng1, Mitchell W Krucoff9.   

Abstract

The MDEpiNet is a public-private partnership between the US Food and Drug Administration's Center for Devices and Radiological Health and participating partners. The PASSION program is an MDEpiNet-sponsored program that aims to demonstrate the goals of MDEpiNet by using cardiovascular medical device registries to bridge evidence gaps across the medical device total product life cycle. To this end, a PASSION Think Tank meeting took place in October 2014 in Silver Spring, MD, to facilitate discussion between stakeholders about the successes, challenges, and future novel applications of medical device registries, with particular emphasis on identifying pilot projects. Participants spanned a broad range of groups including patients, device manufacturers, regulators, physicians/academicians, professional societies, providers, and payers. The meeting focus included 4 areas of cardiovascular medicine intended to cultivate interest in 4 MDEpiNet disease-specific/device-specific working groups: coronary intervention, electrophysiology, valvular disease, and peripheral vascular disease. In addition, more general issues applying to registry-based infrastructure and analytical methodologies for assessing device benefit/risk were considered to provide context for the working groups as PASSION programs going forward. This article summarizes the discussions at the meeting and the future directions of the PASSION program.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26699602      PMCID: PMC4692177          DOI: 10.1016/j.ahj.2015.07.029

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  27 in total

1.  The International Consortium of Orthopaedic Registries: overview and summary.

Authors:  Art Sedrakyan; Elizabeth W Paxton; Charlotte Phillips; Robert Namba; Tadashi Funahashi; Thomas Barber; Thomas Sculco; Douglas Padgett; Timothy Wright; Danica Marinac-Dabic
Journal:  J Bone Joint Surg Am       Date:  2011-12-21       Impact factor: 5.284

Review 2.  Safety and Procedural Success of Left Atrial Appendage Exclusion With the Lariat Device: A Systematic Review of Published Reports and Analytic Review of the FDA MAUDE Database.

Authors:  Saurav Chatterjee; Howard C Herrmann; Robert L Wilensky; John Hirshfeld; Daniel McCormick; David S Frankel; Robert W Yeh; Ehrin J Armstrong; Dharam J Kumbhani; Jay Giri
Journal:  JAMA Intern Med       Date:  2015-07       Impact factor: 21.873

3.  2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Authors:  Patrick T O'Gara; Frederick G Kushner; Deborah D Ascheim; Donald E Casey; Mina K Chung; James A de Lemos; Steven M Ettinger; James C Fang; Francis M Fesmire; Barry A Franklin; Christopher B Granger; Harlan M Krumholz; Jane A Linderbaum; David A Morrow; L Kristin Newby; Joseph P Ornato; Narith Ou; Martha J Radford; Jacqueline E Tamis-Holland; Carl L Tommaso; Cynthia M Tracy; Y Joseph Woo; David X Zhao
Journal:  J Am Coll Cardiol       Date:  2012-12-17       Impact factor: 24.094

4.  Informed consent, comparative effectiveness, and learning health care.

Authors:  Ruth R Faden; Tom L Beauchamp; Nancy E Kass
Journal:  N Engl J Med       Date:  2014-02-20       Impact factor: 91.245

5.  Ethics and regulatory complexities for pragmatic clinical trials.

Authors:  Jeremy Sugarman; Robert M Califf
Journal:  JAMA       Date:  2014-06-18       Impact factor: 56.272

6.  Using vascular quality initiative as a platform for organizing multicenter, prospective, randomized clinical trials: OVERPAR trial.

Authors:  Mohammad H Eslami; Gheorghe Doros; Philip P Goodney; Jens Elderup-Jorgenson; Jack L Cronenwett; Marina Malikova; Alik Farber
Journal:  Ann Vasc Surg       Date:  2014-10-12       Impact factor: 1.466

7.  Results of the destination therapy post-food and drug administration approval study with a continuous flow left ventricular assist device: a prospective study using the INTERMACS registry (Interagency Registry for Mechanically Assisted Circulatory Support).

Authors:  Ulrich P Jorde; Sudhir S Kushwaha; Antone J Tatooles; Yoshifumi Naka; Geetha Bhat; James W Long; Douglas A Horstmanshof; Robert L Kormos; Jeffrey J Teuteberg; Mark S Slaughter; Emma J Birks; David J Farrar; Soon J Park
Journal:  J Am Coll Cardiol       Date:  2014-03-05       Impact factor: 24.094

Review 8.  Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document.

Authors:  A Pieter Kappetein; Stuart J Head; Philippe Généreux; Nicolo Piazza; Nicolas M van Mieghem; Eugene H Blackstone; Thomas G Brott; David J Cohen; Donald E Cutlip; Gerrit-Anne van Es; Rebecca T Hahn; Ajay J Kirtane; Mitchell W Krucoff; Susheel Kodali; Michael J Mack; Roxana Mehran; Josep Rodés-Cabau; Pascal Vranckx; John G Webb; Stephan Windecker; Patrick W Serruys; Martin B Leon
Journal:  J Am Coll Cardiol       Date:  2012-10-09       Impact factor: 24.094

9.  Rethinking composite end points in clinical trials: insights from patients and trialists.

Authors:  Joshua M Stolker; John A Spertus; David J Cohen; Philip G Jones; Kaushik K Jain; Emily Bamberger; Brady B Lonergan; Paul S Chan
Journal:  Circulation       Date:  2014-09-08       Impact factor: 29.690

10.  The Ottawa Statement on the Ethical Design and Conduct of Cluster Randomized Trials.

Authors:  Charles Weijer; Jeremy M Grimshaw; Martin P Eccles; Andrew D McRae; Angela White; Jamie C Brehaut; Monica Taljaard
Journal:  PLoS Med       Date:  2012-11-20       Impact factor: 11.069

View more
  2 in total

1.  One-year follow up of vascular intervention trials disrupted by the COVID-19 pandemic: A use-case landscape.

Authors:  Jennifer A Rymer; Ajay J Kirtane; Andrew Farb; Misti Malone; Michael R Jaff; Kirk Seward; Dan Stephens; Mark R Barakat; Mitchell W Krucoff
Journal:  Cardiovasc Revasc Med       Date:  2022-07-26

2.  Attribution of Adverse Events Following Coronary Stent Placement Identified Using Administrative Claims Data.

Authors:  Sanket S Dhruva; Craig S Parzynski; Ginger M Gamble; Jeptha P Curtis; Nihar R Desai; Robert W Yeh; Frederick A Masoudi; Richard Kuntz; Richard E Shaw; Danica Marinac-Dabic; Art Sedrakyan; Sharon-Lise T Normand; Harlan M Krumholz; Joseph S Ross
Journal:  J Am Heart Assoc       Date:  2020-02-16       Impact factor: 5.501

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.